These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23736690)

  • 1. Genome-wide investigation of multifocal and unifocal prostate cancer-are they genetically different?
    Ibeawuchi C; Schmidt H; Voss R; Titze U; Abbas M; Neumann J; Eltze E; Hoogland AM; Jenster G; Brandt B; Semjonow A
    Int J Mol Sci; 2013 Jun; 14(6):11816-29. PubMed ID: 23736690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-resolution genome-wide copy-number analysis suggests a monoclonal origin of multifocal prostate cancer.
    Boyd LK; Mao X; Xue L; Lin D; Chaplin T; Kudahetti SC; Stankiewicz E; Yu Y; Beltran L; Shaw G; Hines J; Oliver RT; Berney DM; Young BD; Lu YJ
    Genes Chromosomes Cancer; 2012 Jun; 51(6):579-89. PubMed ID: 22334418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic Heterogeneity.
    Løvf M; Zhao S; Axcrona U; Johannessen B; Bakken AC; Carm KT; Hoff AM; Myklebost O; Meza-Zepeda LA; Lie AK; Axcrona K; Lothe RA; Skotheim RI
    Eur Urol; 2019 Mar; 75(3):498-505. PubMed ID: 30181068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic alterations detected in diagnostic prostate biopsies provide an inadequate representation of multifocal prostate cancer.
    Kristiansen A; Bergström R; Delahunt B; Samaratunga H; Guðjónsdóttir J; Grönberg H; Egevad L; Lindberg J
    Prostate; 2019 Jun; 79(8):920-928. PubMed ID: 30908670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial genomic heterogeneity within localized, multifocal prostate cancer.
    Boutros PC; Fraser M; Harding NJ; de Borja R; Trudel D; Lalonde E; Meng A; Hennings-Yeomans PH; McPherson A; Sabelnykova VY; Zia A; Fox NS; Livingstone J; Shiah YJ; Wang J; Beck TA; Have CL; Chong T; Sam M; Johns J; Timms L; Buchner N; Wong A; Watson JD; Simmons TT; P'ng C; Zafarana G; Nguyen F; Luo X; Chu KC; Prokopec SD; Sykes J; Dal Pra A; Berlin A; Brown A; Chan-Seng-Yue MA; Yousif F; Denroche RE; Chong LC; Chen GM; Jung E; Fung C; Starmans MH; Chen H; Govind SK; Hawley J; D'Costa A; Pintilie M; Waggott D; Hach F; Lambin P; Muthuswamy LB; Cooper C; Eeles R; Neal D; Tetu B; Sahinalp C; Stein LD; Fleshner N; Shah SP; Collins CC; Hudson TJ; McPherson JD; van der Kwast T; Bristow RG
    Nat Genet; 2015 Jul; 47(7):736-45. PubMed ID: 26005866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide association study of germline copy number variations reveals an association with prostate cancer aggressiveness.
    Brezina S; Feigl M; Gumpenberger T; Staudinger R; Baierl A; Gsur A
    Mutagenesis; 2020 Jul; 35(3):283-290. PubMed ID: 32255470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional biases in mutation screening due to intratumoural heterogeneity of prostate cancer.
    Kim TM; Jung SH; Baek IP; Lee SH; Choi YJ; Lee JY; Chung YJ; Lee SH
    J Pathol; 2014 Aug; 233(4):425-35. PubMed ID: 24870262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomically versus biologically unifocal prostate cancer: a pathological evaluation in the context of focal therapy.
    Karavitakis M; Ahmed HU; Abel PD; Hazell S; Winkler MH
    Ther Adv Urol; 2012 Aug; 4(4):155-60. PubMed ID: 22852025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
    Rangel-Pozzo A; Liu S; Wajnberg G; Wang X; Ouellette RJ; Hicks GG; Drachenberg D; Mai S
    Cells; 2020 Aug; 9(8):. PubMed ID: 32784507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen.
    Djavan B; Susani M; Bursa B; Basharkhah A; Simak R; Marberger M
    Tech Urol; 1999 Sep; 5(3):139-42. PubMed ID: 10527256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer.
    Liu W; Laitinen S; Khan S; Vihinen M; Kowalski J; Yu G; Chen L; Ewing CM; Eisenberger MA; Carducci MA; Nelson WG; Yegnasubramanian S; Luo J; Wang Y; Xu J; Isaacs WB; Visakorpi T; Bova GS
    Nat Med; 2009 May; 15(5):559-65. PubMed ID: 19363497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor focality is not associated with biochemical outcome after radical prostatectomy.
    Iremashvili V; Pelaez L; Manoharan M; Acosta K; Rosenberg DL; Soloway MS
    Prostate; 2012 May; 72(7):762-8. PubMed ID: 21882214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-assisted three-dimensional analysis of multifocal/multicentric prostate cancer.
    Fujii T; Ishida E; Shimada K; Hirao K; Tanaka N; Fujimoto K; Konishi N
    Cancer Invest; 2014 Aug; 32(7):303-10. PubMed ID: 24827595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copy number signature analysis tool and its application in prostate cancer reveals distinct mutational processes and clinical outcomes.
    Wang S; Li H; Song M; Tao Z; Wu T; He Z; Zhao X; Wu K; Liu XS
    PLoS Genet; 2021 May; 17(5):e1009557. PubMed ID: 33945534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and phenotypic heterogeneity in prostate cancer.
    Haffner MC; Zwart W; Roudier MP; True LD; Nelson WG; Epstein JI; De Marzo AM; Nelson PS; Yegnasubramanian S
    Nat Rev Urol; 2021 Feb; 18(2):79-92. PubMed ID: 33328650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
    Su F; Zhang W; Zhang D; Zhang Y; Pang C; Huang Y; Wang M; Cui L; He L; Zhang J; Zou L; Zhang J; Li W; Li L; Shao J; Ma J; Xiao F; Liu M
    Eur Urol; 2018 Nov; 74(5):551-559. PubMed ID: 29941308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma.
    Bostwick DG; Shan A; Qian J; Darson M; Maihle NJ; Jenkins RB; Cheng L
    Cancer; 1998 Nov; 83(9):1995-2002. PubMed ID: 9806659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer.
    Brocks D; Assenov Y; Minner S; Bogatyrova O; Simon R; Koop C; Oakes C; Zucknick M; Lipka DB; Weischenfeldt J; Feuerbach L; Cowper-Sal Lari R; Lupien M; Brors B; Korbel J; Schlomm T; Tanay A; Sauter G; Gerhäuser C; Plass C;
    Cell Rep; 2014 Aug; 8(3):798-806. PubMed ID: 25066126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival.
    Chen Y; Sadasivan SM; She R; Datta I; Taneja K; Chitale D; Gupta N; Davis MB; Newman LA; Rogers CG; Paris PL; Li J; Rybicki BA; Levin AM
    BMC Med Genomics; 2020 Aug; 13(1):116. PubMed ID: 32819446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring prostate cancer genome reveals simultaneous losses of PTEN, FAS and PAPSS2 in patients with PSA recurrence after radical prostatectomy.
    Ibeawuchi C; Schmidt H; Voss R; Titze U; Abbas M; Neumann J; Eltze E; Hoogland AM; Jenster G; Brandt B; Semjonow A
    Int J Mol Sci; 2015 Feb; 16(2):3856-69. PubMed ID: 25679447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.